Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2023-12-13
DOWNLOAD ISSUE
Donate

Sponsor
Sponsor
Sponsor

  WINDY CITY TIMES

GLMA sends action alert on national health issue for transgender women
From GLMA
2016-09-02

This article shared 687 times since Fri Sep 2, 2016
facebook twitter google +1 reddit email


The Gay and Lesbian Medical Association ( GLMA ) is sending this message from our colleagues at Callen-Lorde, Fenway and Treatment Action Group. GLMA has joined this sign-on effort and encourages individual providers and other LGBT health organizations to do so as well. The deadline to sign-on is Sept 2, 2016.

In collaboration with our LGBT health provider and community partners, Callen-Lorde, Fenway, and Treatment Action Group seek to address the national shortage of injectable estrogen ( in the 40 mg/mL dosage ). We hope that you will review and sign on to the letter below.

The impact of the injectable estrogen shortage poses a serious public health issue for transgender women across the country who rely on hormones to live whole and healthy lives. The shortage is affecting the availability of Delestrogen and its generic counterpart estradiol valerate. Manufacturers spokespeople have said that the products are on back order, but cannot estimate release dates. The shortage began 18 months ago and has not since returned to market. We do not want our communities to turn to street or black market injections, which can contain harmful ingredients. The shortage is generating interesting and important discussion about pushing the FDA to approve estrogen for gender affirmation for trans women, ensuring fair pricing as well as the pros and cons to injectable versus pills and patches.

Recent articles:

- www.theguardian.com/society/2016/aug/09/injectable-estrogen-shortage-transgender-healthcare .

- www.out.com/out-exclusives/2016/8/04/exclusive-theres-injectable-estrogen-shortage-thats-leaving-trans-women/ .

The sign-on letter below urges manufacturers to restock this dosage of estrogen. We hope you'll join this effort. Please review the letter below and sign on using this link ( feel free to share with your networks as well ): www.surveymonkey.com/r/R9MFNBQ. The deadline to sign on is September 2, 2016 .

Text of the letter is below.

Paul Campanelli

President

Par Pharmaceutical at Endo International PLC

One Ram Ridge Rd

Chestnut Ridge, NY 10977

John Hendrickson

Chief Executive Officer

Perrigo, Inc.

515 Eastern Avenue

Allegan, MI 49010

September 2016

Dear President Campanelli and CEO Hendrickson:

We the undersigned — physicians, public health professionals, advocates and members of the lesbian, gay, bisexual ( LGB ), transgender and gender non-conforming ( TG/NC ) communities — write to share our deep concern about the national shortage of injectable estrogen. We urge that Par Sterile and Perrigo Pharmaceuticals restock and manufacture injectable estradiol in 40 mg/mL dosages. The impact of this shortage is a public health emergency for thousands of transgender women who rely on these hormones to live whole and healthy lives.

Hormone therapy to affirm gender identity is a medically necessary intervention for many transgender individuals.[1] It is often the first, and sometimes only, medical gender affirmation intervention accessed by transgender individuals looking to develop characteristics consistent with their gender identity.[2] Studies have shown that gender affirmation through hormone therapy can improve psychological adjustment and quality of life.[3],[4] One study found that once estrogen therapy began, transgender women experienced improvement in social functioning and reduced anxiety and depression.[5] The class of estrogen used for feminizing therapy is 17-beta estradiol and is commonly delivered to transgender women through a patch, oral or sublingual tablet, or injection.[6]

Further, in the last 10 years, many professional associations, including the American Medical Association, American Association of Family Physicians, the Endocrine Society, American Psychiatric Association, American Psychological Association, American College of Obstetricians and Gynecologists, and the American Public Health Association, have issued statements or guidelines supporting effective treatment protocols for Gender Dysphoria, and review articles have been published in major peer-reviewed journals such as the Journal of the American Medical Association, Nature, the Journal of Clinical Endocrinology, and Archives of Pediatric and Adolescent Medicine, among others.[7]

As you are aware, there is a current shortage of estradiol valerate Injection.[8] This shortage is affecting the availability of Delestrogen and its generic counterpart estradiol valerate. The shortage includes Delestrogen injection from Par Sterile Products and estradiol valerate injection from Perrigo, in both the 20 mg/mL and 40 mg/mL formulations. We understand from Par and Perrigo spokespersons that there is a manufacturing delay for Delestrogen as well as manufacturing issues for the generic counterpart. We also understand that both companies have these products on back order, but cannot estimate release dates. While Delestrogen injection is currently available from Par Sterile Products in the 10 mg/mL formulation, [9] injectable estrogen at the 40 mg/mL dosage is the highest dosage and very often prescribed to transgender women in our experience.[10] The shortage began 18 months ago and has not since returned to the market. In July 2016, a federally-qualified health center based in New York City received none of the 40 mg/mL and 20 mg/mL formulations in their weekly drug shipment and were told that the shortage would last until at least October.[11] This shortage impacts 900 transgender women at that clinic alone.

Due to the severity of the effects of this shortage on the wellbeing of transgender women, we urge you — the manufactures — to take immediate action by restocking the 40 mg/mL dosage of injectable estrogen in both brand and generic versions.

Manufacturers need to restore the 40 mg/mL dosage of injectable estrogen because it is the preferred regimen for many transgender women. Many patients started their transition with injectable estrogen years ago and rely on regular injections. Further, many transgender women on hormone therapy for gender affirmation experience injectables as more effective than patches or pills. Some providers are working to educate patients about the efficacy of patches and pills; but this does not negate the immediate need for injectable estrogen.

While the 40 mg/mL dosage has been unavailable, providers have made due by doubling up on the 20 mg/mL dosage. This is a temporary work-around as some patients report discomfort with the injections. Most providers will not prescribe the 10 mg/mL dosage. In order to maintain the estrogen levels that patients were able to achieve with the 40 mg/mL dosage, patients would need to inject four times as much liquid into their muscles every one to two weeks, which can be very painful for patients.

The lack of injectable estrogen is a public health crisis. Patients could likely turn to street injections to replace what they were receiving in clinics, which could put themselves at risk. Black market injectable estrogen is often diluted or laced with other potentially harmful ingredients. This shortage could contribute to further marginalization of the transgender community, putting women at risk of injecting adulterated estrogen.

The shortage of this preferred method of gender affirmation therapy has already created obstacles for clinicians to be able to provide comprehensive care to transgender patients. This injectable estrogen shortage is triggered by a lack of FDA-approval for all estrogen modalities. Therefore, the FDA should also take action by approving estrogen for gender affirmation, affording transgender women the same range of choices as menopausal women are currently given. Advocates are working to this end.

In the meantime, thousands of transgender women across the United States are unable to access injectable estrogen thereby putting their health and lives in danger. We urge Par Sterile and Perrigo Pharmaceuticals to restock the 40 mg/mL dosage of injectable estrogen immediately. If helpful, we can arrange a conference call to discuss this further.

Please feel free to contact Kimberleigh J. Smith, Senior Director for Community Health Planning and Policy at the Callen-Lorde Community Health Center in New York City with questions and/or to send a response to this request: ksmith@callen-lorde.org or 212-271-7184.

Sign on list in formation


This article shared 687 times since Fri Sep 2, 2016
facebook twitter google +1 reddit email

Out and Aging
Presented By

  ARTICLES YOU MIGHT LIKE

Gay News

NATIONAL Political candidates, flag controversy, HRC gala, New York Times, Disney
2024-03-29
In California, of the historic 30 LGBTQ+ legislative candidates who ran in the March 5 primary, more than half are moving on to the fall ballot, The Bay Area Reporter noted. Based on the still unofficial ...


Gay News

WORLD Israel court, conversion therapy, death sentences, Georgia bill, fashion items
2024-03-29
Israel's Supreme Court unanimously ruled that the Population Authority must register female couples as mothers on the birth certificates of their children they have together, The Washington Blade reported. The decision was made following a petition ...


Gay News

Lambda Legal Launches "Speak OUT" awareness campaign uplifting trans, nonbinary voices
2024-03-28
--From a press release. VIDEO BELOW - (NEW YORK, NY — March 28, 2024) In advance of Transgender Day of Visibility, Lambda Legal, the nation's oldest and largest legal nonprofit working to achieve full equal rights for LGBTQ people and everyone living with ...


Gay News

Nex Benedict's autopsy report released
2024-03-27
The full autopsy report for Nex Benedict (he/they)—a 16-year-old transgender and Indigenous student from Oklahoma's Owasso High School who died in February a day after a school fight—has been released. The Oklahoma Office of the Chie ...


Gay News

Brown Elephant Returns To Northalsted
2024-03-26
Brown Elephant's Lake View location is moving to Northalsted and already accepting donations. Howard Brown Health, the largest LGBTQ+ health center in the midwest, operates three Brown Elephant resale shops in the Chicagoland area to help ...


Gay News

An interstate trans healthcare crisis: Illinois prepares for influx of people seeking gender-affirming care
2024-03-26
With hard-won rights, such as access to hormone replacement therapy or permission to use one's chosen pronouns in school, breaking down in states across the country, trans residents of all ages are left with a choice: ...


Gay News

Planned Parenthood of Illinois expands Orland Park health center
2024-03-26
--From a press release - ORLAND PARK, Ill. - Planned Parenthood of Illinois (PPIL) announces the expansion of its existing Orland Park Health Center at 14470 S. LaGrange Rd., Suite 106. The 1,800-square-foot expansion is projected to increase sexual and reproductive ...


Gay News

Wyoming is latest state to ban gender-affirming care for minors
2024-03-24
On March 22, Wyoming became the latest state to prohibit gender-affirming care for minors, The Hill noted. In doing so, it joined 23 other states that passed laws restricting or banning the treatment. Legislators in both ...


Gay News

No charges filed in Nex Benedict fight; campaigns call for Walters' removal
2024-03-22
In Oklahoma, Tulsa County District Attorney Stephen Kunzweiler announced that no charges will be filed in connection with the fight that happened the day before transgender, nonbinary high school student Nex Benedict died by suicide, NBC ...


Gay News

JP Karliak morphs into non-binary character for Disney+'s X-Men '97
2024-03-22
series X-Men '97, a revival of the popular X-men: The Animated Series that's both continuing the ongoing mutant storyline and breaking new ground along the way. The character of Morph now looks more like the comic ...


Gay News

NATIONAL Va. marriage bill, AARP, online counseling, Idaho items, late activist
2024-03-21
Republican Virginia Gov. Glenn Youngkin signed bills protecting same-sex marriages at a state level, surprising some, WRIC reported. The bills—passed out of both chambers along mostly party lines—will require clerks ...


Gay News

Chicago's LGBTQ+ Advisory Council sets a new course
2024-03-18
Chicago's LGBTQ+ Advisory Council held its first meeting of the calendar year on Feb. 28 at City Hall in the Loop under the leadership of the recently appointed chair Jin-Soo Huh. The LGBTQ+ Advisory Council is ...


Gay News

Almost 8% of U.S. residents identify as LGBTQ+
2024-03-16
The proportion of U.S. adults identifying as LGBTQ+ continues to increase. LGBTQ+ identification in the U.S. continues to grow, with 7.6% of U.S. adults now identifying as LGBTQ+, according to the newest Gallup poll results that ...


Gay News

WORLD Leaked messages, Panama action, author dies at 32, Japan court, out athletes
2024-03-15
Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a report and framed as revealing serious health risks associated with gender-affirming care, including cancer, according to ...


Gay News

NATIONAL Missouri measure, HIV/AIDS Awareness Day, judge, Texas schools
2024-03-15
In Missouri, a newly proposed law could charge teachers and counselors with a felony and require them to register as sex offenders if they're found guilty of supporting transgender students who are socially transitioning, CNN noted. ...


 


Copyright © 2024 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.

All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transgender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 
 

TRENDINGBREAKINGPHOTOS







Sponsor


 



Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam     
Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.